Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Patents & EXCLUSIVITIES
Health Canada Patents
Patent Expiration Date : 2028-02-14
Date Granted : 2016-07-26
Brand Name : CRYSVITA
Patent Number : 2677782
Filing Date : 2008-02-14
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-02-14
Date Granted : 2016-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2023-01-06
Date Granted : 2012-07-31
Brand Name : CRYSVITA
Patent Number : 2471656
Filing Date : 2003-01-06
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2023-01-06
Date Granted : 2012-07-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-08-10
Date Granted : 2012-10-23
Brand Name : CRYSVITA
Patent Number : 2418802
Filing Date : 2001-08-10
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-08-10
Date Granted : 2012-10-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-02-14
Date Granted : 2016-07-26
Brand Name : CRYSVITA
Patent Number : 2677782
Filing Date : 2008-02-14
Strength per Unit : 20 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-02-14
Date Granted : 2016-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2023-01-06
Date Granted : 2012-07-31
Brand Name : CRYSVITA
Patent Number : 2471656
Filing Date : 2003-01-06
Strength per Unit : 20 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2023-01-06
Date Granted : 2012-07-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-08-10
Date Granted : 2012-10-23
Brand Name : CRYSVITA
Patent Number : 2418802
Filing Date : 2001-08-10
Strength per Unit : 20 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-08-10
Date Granted : 2012-10-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-02-14
Date Granted : 2016-07-26
Brand Name : CRYSVITA
Patent Number : 2677782
Filing Date : 2008-02-14
Strength per Unit : 30 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-02-14
Date Granted : 2016-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2023-01-06
Date Granted : 2012-07-31
Brand Name : CRYSVITA
Patent Number : 2471656
Filing Date : 2003-01-06
Strength per Unit : 30 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2023-01-06
Date Granted : 2012-07-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-08-10
Date Granted : 2012-10-23
Brand Name : CRYSVITA
Patent Number : 2418802
Filing Date : 2001-08-10
Strength per Unit : 30 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-08-10
Date Granted : 2012-10-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-05-29
Date Granted : 2022-03-22
Brand Name : CRYSVITA
Patent Number : 2949234
Filing Date : 2015-05-29
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2035-05-29
Date Granted : 2022-03-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
